Loading clinical trials...
Loading clinical trials...
A Phase 4, Open-Label, Single-Arm Study to Evaluate the Effects of Vogelxo(R) on 24-hour Ambulatory Blood Pressure Monitoring in Hypogonadal Men Using Therapeutic Testosterone Replacement Therapy
Conditions
Interventions
Vogelxo
Locations
7
United States
Upsher-Smith Clinical Trial Site #6
Birmingham, Alabama, United States
Upsher-Smith Clinical Trial Site #2
Anaheim, California, United States
Upsher-Smith Clinical Trial Site #1
Miami, Florida, United States
Upsher-Smith Clinical Trials Site #7
Garden City, New York, United States
Upsher-Smith Clinical Trials Site #4
North Charleston, South Carolina, United States
Upsher-Smith Clinical Trials Site #5
San Antonio, Texas, United States
Start Date
August 28, 2020
Primary Completion Date
December 12, 2023
Completion Date
January 11, 2024
Last Updated
October 18, 2024
NCT06689085
NCT06841328
NCT03851627
NCT06094036
NCT05381831
NCT04326673
Lead Sponsor
Upsher-Smith Laboratories
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions